Olatec Therapeutics
PrivateLast Round
Series B
Nov 9, 2025
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Olatec Therapeutics is a biopharmaceutical company that develops oral small-molecule therapeutics targeting the NLRP3 inflammasome and Interleukin-1 pathways to treat inflammatory and immune-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Olatec Therapeutics Comparables
Compare Olatec Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NodThera | 87% | |
| IFM Therapeutics | 86% | |
| Halia Therapeutics | 86% |
Olatec Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 9, 2025 | ||||
| Grant | Feb 20, 2024 | ||||
| Grant | Mar 10, 2023 | ||||
| Series A | Feb 23, 2023 |
Olatec Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advection Growth Capital | Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Cure Parkinson's | Grant |
| Van Andel Institute | Grant |
| Sanders Morris Harris | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 156% MoM.
- Oct 2, 2025
Andy Cunningham joins the Board of Directors.
Recent news
Latest coverage and updates
- hiresSep 15, 2026
Olatec Therapeutics Llc. hired David Haase as Board of Directors and the Clinical Advisory Board on Sep 15th '26.
Olatec Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Olatec Therapeutics's valuation, stock price, and market status.
Is Olatec a public or private company?
Olatec is a private company.
What is the current stock price of Olatec?
Olatec is a private company with no public stock price. No recent secondary market data is available.
How much is Olatec worth (valuation)?
Valuation information for Olatec is not publicly available.
Can I buy Olatec stock?
Olatec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Olatec's last funding round?
Olatec's most recent funding round was Series B on November 9, 2025.
Who are the main investors in Olatec?
Key investors in Olatec include Cure Parkinson's, Sanders Morris Harris.
Will Olatec IPO soon?
No public IPO plans have been announced for Olatec.
How can I track Olatec secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Olatec's secondary market activity and sign up for updates.